Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Infertility Ivf Ehb topic
No spam. Unsubscribe anytime.
Lawmakers and advocates press California to add infertility care, including IVF, to essential health benefits
Summary
Clinicians, advocates and lawmakers urged adding infertility diagnosis and treatment — including IVF — to California’s essential health benefits; actuaries presented multiple IVF packages, and the state must choose a benefit design that fits the federal "typicality" ceiling and any submission timetable.
Advocates, clinicians and some legislators urged the committee to include infertility diagnosis and treatment — including IVF — in California’s essential health benefits during the Feb. 11 informational hearing.
Wakely Consulting Group presented multiple IVF benefit packages and price points. Matt Slaughter said the firm priced three illustrative IVF pathways with varying levels of coverage; Wakely’s marginal estimates for the IVF options ranged roughly 0.61% to 0.87% of allowed costs depending on benefit richness and included items such as egg/sperm retrieval, cryopreservation and varying numbers of embryo transfers. "These represent just 3. There are leaner options, there are richer options," Slaughter said, noting that unit costs and storage assumptions materially affect the marginal impact.
CHBRP provided a separate premium-impact estimate expressed in per-member-per-month (PMPM) dollars and tied its analysis to previously introduced legislation (SB 729). CHBRP estimated a PMPM impact for the fertility package it modeled at approximately $0.0536 per member per month for the silver plan scenario it used in its rapid analysis; CHBRP staff stressed its report assumed no baseline coverage and that its estimates were produced in a short turnaround.
Public testimony and clinical perspective
Multiple public witnesses described the financial and emotional burden of infertility and urged the Legislature to adopt a robust IVF benefit. One public commenter said: "We need IVF to have a child," and others described out‑of‑state care and six‑figure out‑of‑pocket costs. Reproductive health clinicians recommended a package aligned with clinical practice; Dr. Anna Yap (a practicing physician) urged adoption of the more comprehensive pathway that she said aligns with American Society for Reproductive Medicine guidance.
Legal and implementation considerations
Speakers clarified that nondiscrimination requirements and benefit definitions matter for how coverage would be applied to all family types, including same‑sex and single‑parent pathways; advocates urged the state to adopt an inclusive definition of infertility that covers assisted reproductive technologies used by LGBTQ+ people. Wakely and DMHC staff said the state could craft benefit definitions but must ensure any chosen package also meets the CMS typicality ceiling and fits the May submission timeline if they seek a 2027 effective date.
Next steps
Committee chairs and agency staff asked advocates and insurers to provide more detailed submissions and asked Wakely/CHBRP to refine price points as requested. Advocates said they supported the most clinically complete option (the higher-cost pathway), while some committee members and insurers noted tradeoffs between comprehensiveness and premium impact under the actuarial ceiling. No formal vote was taken at the hearing.
